BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6501991)

  • 1. [Hormonal profiles and structures in normal women and in patients with benign and malignant breast diseases].
    Imayoshi E; Soga H; Nomura S; Komatsubara S; Satoh G; Teramoto S; Fukuda K; Takashima S
    Nihon Gan Chiryo Gakkai Shi; 1984 Jun; 19(5):1014-20. PubMed ID: 6501991
    [No Abstract]   [Full Text] [Related]  

  • 2. Twenty-four-hour preoperative endocrine profiles in women with benign and malignant breast disease.
    Malarkey WB; Schroeder LL; Stevens VC; James AG; Lanese RR
    Cancer Res; 1977 Dec; 37(12):4655-9. PubMed ID: 922746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benign breast disease I: hormonal investigation.
    Sitruk-Ware R; Sterkers N; Mauvais-Jarvis P
    Obstet Gynecol; 1979 Apr; 53(4):457-60. PubMed ID: 571588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prolactin and steroid hormones in the blood in local disorders of the lymph-plasma circulation in breast cancer patients].
    Berzin SA; Tokar' VN
    Sov Med; 1988; (12):16-9. PubMed ID: 3242113
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum androgen levels and the menstrual cycle in women with benign or malignant breast disease.
    England PC; Sellwood RA; Knyba RE; Irvine JD
    Clin Oncol; 1981 Sep; 7(3):213-9. PubMed ID: 6211319
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnosis and treatment of mastopathy.
    Márton Z; Gáti I; Doszpod J; Preisz J; Kecskés L
    Acta Chir Acad Sci Hung; 1969; 10(1):93-103. PubMed ID: 4240634
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mastopathy and breast cancer: is there a typical hormone profile?].
    Völker W; Leipert KP; Gehrlings H; Stauch G; von zur Mühlen A; Schneider J
    Geburtshilfe Frauenheilkd; 1986 May; 46(5):284-9. PubMed ID: 3087811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diacetyl-splenopentin (BCH 069) did not affect the concentrations of various hormones in men.
    Simon HU; Lauterbach H; Börner A; Wachtel S
    Exp Clin Endocrinol; 1990 Dec; 96(3):314-6. PubMed ID: 2083571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone concentrations in postmenopausal patients with breast cancer.
    Jones MK; Ramsay ID; Booth M; Collins WP
    Clin Oncol; 1977 Jun; 3(2):177-81. PubMed ID: 872471
    [No Abstract]   [Full Text] [Related]  

  • 10. [The gonadotropin, prolactin, estradiol, progesterone and cortisol ratios in the normal menstrual cycle in women from the northeastern USSR].
    Pirogov AB; Maslova LV; Mavrina II
    Fiziol Cheloveka; 1990; 16(2):83-9. PubMed ID: 2373321
    [No Abstract]   [Full Text] [Related]  

  • 11. Luteal phase hyperprolactinemia.
    Falk RJ; Anderson L
    Int J Fertil Menopausal Stud; 1994; 39(5):272-7. PubMed ID: 7820160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum hormones in human breast cancer subjects.
    Krishnamoorthy G; Govindarajulu P; Ramalingam V
    Neoplasma; 1989; 36(2):221-31. PubMed ID: 2497392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Benign breast diseases: hormonal studies in 125 cases (author's transl)].
    Mauvais-Jarvis P; Kuttenn F; Mowszowicz I; Sitruk-Ware R
    Nouv Presse Med; 1977 Dec; 6(44):4115-8. PubMed ID: 600762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum hormonal activities in normal women and in patients with breast cancer].
    Imayoshi E; Fukuda K; Teramoto S; Kamata S; Sakaguchi I; Hirai R; Takashima S
    Nihon Gan Chiryo Gakkai Shi; 1983 Oct; 18(7):1852-8. PubMed ID: 6231345
    [No Abstract]   [Full Text] [Related]  

  • 15. Thyroid-stimulating hormone and prolactin levels in breast cancer.
    Aldinger KA; Schultz PN; Blumenschein GR; Samaan NA
    Arch Intern Med; 1978 Nov; 138(11):1638-41. PubMed ID: 102267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian profiles of cortisol, prolactin, and thyrotropin in seasonal affective disorder.
    Oren DA; Levendosky AA; Kasper S; Duncan CC; Rosenthal NE
    Biol Psychiatry; 1996 Feb; 39(3):157-70. PubMed ID: 8837977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Steroid hormone receptors in the normal breast and in benign mastopathies].
    Kouyoumdjian JC; Feuilhade F; Pinaudeau Y; Rymer JC
    Bull Cancer; 1986; 73(2):120-3. PubMed ID: 3730631
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of benign fibrocystic disease of the breast with 2-bromo-alpha-ergocryptine (CB 154).
    Santoro C; Cappa M; Moretti C; Fabbri A; La Vecchia V; Romano Marcellino L; Fraioli F
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):479-81. PubMed ID: 6815107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Estrogen receptor kinetics in benign and malignant diseases of the breast and their clinical implication].
    Ebuchi M
    Nihon Geka Gakkai Zasshi; 1987 Jun; 88(6):746-54. PubMed ID: 3627097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hormonal function of the ovarian corpus luteum during benign mammary diseases].
    Mauvais-Jarvis P; Tamborini A; Sterkers N; Ohlgiesser G; Mowszowicz I
    J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):965-70. PubMed ID: 1219052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.